Ezetimibe Tablet
Product Images NDC 82009-024

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ezetimibe (NDC 82009-024). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ezetimibe Tablets, 10 mg (57cb59f3 D54e 4a2e B6ed B872869d1368 01)

Chemical structure of ezetimibe, depicting its molecular arrangement including phenyl rings, fluorine atoms, hydroxyl groups, and a sulfur atom within its molecular framework.*

FDA Label Image

Ezetimibe Tablets, 10 mg (57cb59f3 D54e 4a2e B6ed B872869d1368 02)

Label for Ezetimibe Tablets, USP 10 mg by Quallent Pharmaceuticals Health LLC. The oral tablet is packaged in a container of 500 tablets. The label includes dosage information, storage instructions, and manufacturer details including Zydus Lifesciences Ltd. and Quallent Pharmaceuticals Health LLC. The label also features barcodes and regulatory details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.